Literature DB >> 20674395

Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery?

Jean-Luc Fellahi1, Georges Daccache, David Rubes, Massimo Massetti, Jean-Louis Gérard, Jean-Luc Hanouz.   

Abstract

OBJECTIVES: Although B-type natriuretic peptide (BNP) strongly predicts cardiac morbidity and mortality, the European System for Cardiac Operative Risk Evaluation (EuroSCORE) has a modest predictive value to identify a composite operative risk after cardiac surgery. The authors tested the hypothesis that a single preoperative BNP measurement would be superior to standard EuroSCORE in predicting composite adverse outcomes after cardiac surgery.
DESIGN: A prospective observational study.
SETTING: A teaching university hospital. PARTICIPANTS: Two hundred eight adult patients.
INTERVENTIONS: Conventional cardiac surgery with cardiopulmonary bypass.
MEASUREMENTS AND MAIN RESULTS: The preoperative additive EuroSCORE and BNP measurement were performed in all patients. Postoperative nonfatal major adverse cardiac events (malignant ventricular arrhythmia, myocardial infarction, and cardiac dysfunction), all-cause mortality, and prolonged lengths of stay were chosen as study endpoints. Predictive abilities of both EuroSCORE and BNP were assessed using logistic regression and compared with receiver operating characteristic (ROC) curves. Thirty-six (17%, 95% confidence interval [CI], 12%-22%) patients experienced 49 events over the study period. The areas under the ROC curves assessing the utility of EuroSCORE and BNP in predicting adverse outcome and prolonged in-hospital stay were 0.59 (95% CI, 0.48-0.69) versus 0.76 (95% CI, 0.68-0.85; p < 0.001) and 0.65 (95% CI, 0.57-0.74) versus 0.71 (95% CI, 0.63-0.80; p = 0.147), respectively. Using logistic regression, BNP considered as a dichotomized variable was the only independent predictor of adverse cardiac outcome (adjusted odds ratio = 10.7; 95% CI, 4.1-27.8; p < 0.001).
CONCLUSIONS: Preoperative BNP measurement is a strong, independent, and more accurate predictor of adverse outcome than EuroSCORE in patients undergoing cardiac surgery. BNP could be considered as a simple and objective tool for the detection of high-risk patients after cardiac surgery.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674395     DOI: 10.1053/j.jvca.2010.05.009

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery.

Authors:  Uptal D Patel; Amit X Garg; Harlan M Krumholz; Michael G Shlipak; Steven G Coca; Kyaw Sint; Heather Thiessen-Philbrook; Jay L Koyner; Madhav Swaminathan; Cary S Passik; Chirag R Parikh
Journal:  Circulation       Date:  2012-02-09       Impact factor: 29.690

2.  Clinical value of BNP as an independent predictor of mortality following heart surgery.

Authors:  Edmo Atique Gabriel
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

3.  Predictors of mortality in cardiac surgery: brain natriuretic peptide type B.

Authors:  Jamil Alli Murad Junior; Marcelo Arruda Nakazone; Mauricio de Nassau Machado; Moacir Fernandes de Godoy
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

4.  In-hospital mortality is associated with high NT-proBNP level.

Authors:  Malik Benmachiche; Pedro Marques-Vidal; Gérard Waeber; Marie Méan
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

5.  High levels of B-type natriuretic peptide predict weaning failure from mechanical ventilation in adult patients after cardiac surgery.

Authors:  Thiago Martins Lara; Ludhmila Abrahao Hajjar; Juliano Pinheiro de Almeida; Julia Tizue Fukushima; Carmem Silvia Valente Barbas; Adriano Rogerio Baldacin Rodrigues; Emilia Nozawa; Maria Ignes Zanetti Feltrim; Elisangela Almeida; Vera Coimbra; Eduardo Osawa; Rafael de Moraes Ianotti; Alcino Costa Leme; Fabio Biscegli Jatene; Jose Otavio Costa Auler; Filomena Regina Barbosa Gomes Galas
Journal:  Clinics (Sao Paulo)       Date:  2013-01       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.